Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Lemtrada

Drug Multiple Sclerosis

NDC 58468-0200-1

Open in the dashboard

General payments

$4,078,096

11,274 payments

Research payments

$3,262,590

947 payments

Through program year 2019, $4,078,096 in general payments and $3,262,590 in research payments were reported against Lemtrada (Multiple Sclerosis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $4,078,096 11,274
2019 Research $3,262,590 947

Breakdown

Who paid General payments · program year 2019
  1. Genzyme Corporation $3,717,987 11,105 payments
  2. Sanofi-Aventis U.S. LLC $360,109 169 payments
Top recipients General payments · program year 2019
  1. Bhupendra Khatri Neurology · Milwaukee, WI $233,910 6% · 116 payments
  2. Aaron Boster Neurology · Columbus, OH $127,139 3% · 131 payments
  3. Ann Bass Neurology · San Antonio, TX $125,571 3% · 95 payments
  4. Daniel Becker Neurology · Lutherville, MD $106,884 3% · 94 payments
  5. Barry Singer Neurology · Saint Louis, MO $87,291 2% · 47 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Neurology Psychiatry & Neurology $3,645,246 92% · 1,883 practitioners
  2. Nephrology Internal Medicine $50,942 1% · 10 practitioners
  3. Pediatric Hematology-Oncology Pediatrics $40,601 1% · 1 practitioner
  4. Neuromuscular Medicine Psychiatry & Neurology $38,380 <1% · 15 practitioners
  5. Neurology with Special Qualifications in Child Neurology Psychiatry & Neurology $38,008 <1% · 24 practitioners

The top 5 of 61 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Florida $342,356 8% · 198 recipients
  2. Texas $323,334 8% · 133 recipients
  3. Wisconsin $267,460 7% · 11 recipients
  4. California $266,200 7% · 137 recipients
  5. New York $234,329 6% · 172 recipients

The top 5 of 52 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

11,274 general · 947 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record